ZA926969B - New beta-carboline derivatives, their production and use in pharmaceutical agents. - Google Patents

New beta-carboline derivatives, their production and use in pharmaceutical agents.

Info

Publication number
ZA926969B
ZA926969B ZA926969A ZA926969A ZA926969B ZA 926969 B ZA926969 B ZA 926969B ZA 926969 A ZA926969 A ZA 926969A ZA 926969 A ZA926969 A ZA 926969A ZA 926969 B ZA926969 B ZA 926969B
Authority
ZA
South Africa
Prior art keywords
production
pharmaceutical agents
new beta
carboline derivatives
carboline
Prior art date
Application number
ZA926969A
Other languages
English (en)
Inventor
Andreas Huth
Dieter Seidelmann
Dieter Rahtz
Ralph Schmiechen
Herbert Schneider
Lechoslaw Turski
Margit Hillmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA926969B publication Critical patent/ZA926969B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA926969A 1991-09-13 1992-09-11 New beta-carboline derivatives, their production and use in pharmaceutical agents. ZA926969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4130933A DE4130933A1 (de) 1991-09-13 1991-09-13 Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
ZA926969B true ZA926969B (en) 1993-03-17

Family

ID=6440817

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA926969A ZA926969B (en) 1991-09-13 1992-09-11 New beta-carboline derivatives, their production and use in pharmaceutical agents.

Country Status (17)

Country Link
US (1) US5506234A (pt)
EP (1) EP0557497A1 (pt)
JP (1) JPH06502871A (pt)
KR (1) KR930703313A (pt)
CN (1) CN1033391C (pt)
AU (1) AU655503B2 (pt)
CA (1) CA2096138A1 (pt)
CZ (1) CZ72593A3 (pt)
DE (1) DE4130933A1 (pt)
FI (1) FI932145A0 (pt)
HU (1) HUT64343A (pt)
IL (1) IL103151A0 (pt)
MX (1) MX9205164A (pt)
NZ (1) NZ244328A (pt)
PT (1) PT100860A (pt)
WO (1) WO1993006100A1 (pt)
ZA (1) ZA926969B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330175A1 (de) * 1993-08-31 1995-03-02 Schering Ag Alkoxy-substituierte beta-Carboline
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
DE19514524A1 (de) * 1995-04-12 1996-10-17 Schering Ag Anellierte beta-Carboline
CN1290893C (zh) * 2002-05-03 2006-12-20 詹森药业有限公司 聚合物微乳状液
US7504401B2 (en) 2003-08-29 2009-03-17 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
EP2240481A1 (en) 2008-01-11 2010-10-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
WO2011003021A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003005A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en) * 2009-07-01 2014-01-14 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011158108A2 (en) 2010-06-16 2011-12-22 Purdue Pharma L.P. Aryl substituted indoles and the use thereof
EP2455378A1 (en) 2010-11-03 2012-05-23 Philip Morris Products S.A. Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
WO2012088124A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
WO2012088038A2 (en) 2010-12-21 2012-06-28 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DK240084D0 (da) * 1984-05-15 1984-05-15 Ferrosan As New beta-carboline-3-oxadiazolyl derivatives
DE3504045A1 (de) * 1985-02-04 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von ss-carbolinen durch dehydrierung
DE3545776A1 (de) * 1985-12-20 1987-06-25 Schering Ag 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU619203B2 (en) * 1987-08-28 1992-01-23 Schering Aktiengesellschaft Isoxazole-beta-carboline derivatives
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE3943225A1 (de) * 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
FI932145A (fi) 1993-05-12
NZ244328A (en) 1995-02-24
CN1033391C (zh) 1996-11-27
IL103151A0 (en) 1993-02-21
CZ72593A3 (en) 1994-01-19
HUT64343A (en) 1993-12-28
EP0557497A1 (de) 1993-09-01
WO1993006100A1 (de) 1993-04-01
HU9301379D0 (en) 1993-09-28
AU2557892A (en) 1993-04-27
FI932145A0 (fi) 1993-05-12
PT100860A (pt) 1993-11-30
MX9205164A (es) 1993-03-01
CA2096138A1 (en) 1993-03-14
AU655503B2 (en) 1994-12-22
KR930703313A (ko) 1993-11-29
CN1070403A (zh) 1993-03-31
JPH06502871A (ja) 1994-03-31
DE4130933A1 (de) 1993-03-18
US5506234A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
ZA914296B (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
HU9301877D0 (en) Quinoxaline derivatives, their production and utilization in pharmaceutical preparatives
ZA926969B (en) New beta-carboline derivatives, their production and use in pharmaceutical agents.
ZA917853B (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
HU9202864D0 (en) Gycinamide derivatives, their production and pharmaceutical preparatives containing them
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
ZA926189B (en) Beta-Phenylisoserine derivatives and their preparation and use.
EP0672052A1 (en) TACHYQUININ ANTAGONISTS, THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
ZA927506B (en) New drug formulation.
EP0488220A3 (en) Pyridone derivatives, and their production and use
AU647608B2 (en) Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents
AU1858692A (en) 2-piperidinylpyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
ZA927154B (en) Indolesulphonamide-substituted dihydropyridines, processes for their preparation and their use in medicaments.
GB2253851B (en) Pyridine derivatives,their preparation and pharmaceutical use
EP0583698A3 (en) Deoxy-cyclitol derivatives, process for their preparation and their use in medicaments.
IL97859A0 (en) 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use
AU1867497A (en) New quinoxalindione derivatives, their production and use in pharmaceutical agents
HU9400417D0 (en) New leukotriene-b4 antagonists, methods for producing them and their use as drugs
ZA942972B (en) New quinoxalinedione derivatives, their production and use in pharmaceutical agents.
EP0643060A3 (de) Sulfonylbenzyl-substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
ZA928197B (en) Bemzodiazepine derivatives, compositions containing them and their use in therapy.